This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Prostate cancer epidemiology in the United States - Abstract
May 29, 2012
Q Fever masquerading as prostate cancer metastases - Abstract
May 28, 2012
Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings - Abstract
May 28, 2012
Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer - Abstract
May 28, 2012
Health economics evaluation of magnetic resonance imaging for the staging of prostate cancer for Austria and Germany - Abstract
May 28, 2012
Novel agents for the management of castration-resistant prostate cancer - Abstract
May 28, 2012
Overcoming castration resistance in prostate cancer - Abstract
May 28, 2012
Analysis of inter-fraction setup errors and organ motion by daily kilovoltage cone beam computed tomography in intensity modulated radiotherapy of prostate cancer - Abstract
May 28, 2012
Prostate-specific antigen levels in men aged 70 years and over: Findings from the CHAMP study - Abstract
May 28, 2012
Patient knowledge about prostate-specific antigen (PSA) and prostate cancer in Australia - Abstract
May 28, 2012
Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool - Abstract
May 25, 2012
RNASEL study of genetics of prostate cancer and its relation to clinical staging - Abstract
May 25, 2012
3.0 T multiparametric prostate MRI using pelvic phased-array coil: Utility for tumor detection prior to biopsy - Abstract
May 25, 2012
MRI in addition to or as a substitute for prostate biopsy: The clinician's point of view - Abstract
May 25, 2012
Clinical significance of free-to-total prostate-specific antigen (PSA) ratio in advanced prostate cancer patients with PSA less than 0.1 ng/ml after hormone treatment - Abstract
May 25, 2012
Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population - Abstract
May 25, 2012
Advanced prostate cancer: Treatment and patient-centred care - Abstract
May 25, 2012
Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy - Abstract
May 25, 2012
ACR Appropriateness Criteria® external-beam radiation therapy treatment planning for clinically localized prostate cancer - Abstract
May 25, 2012
Prostate weight is the preferred measure of prostate size in radical prostatectomy cohorts - Abstract
May 25, 2012
Page 1273 of 1420
Start
Prev
1268
1269
1270
1271
1272
1273
1274
1275
1276
1277
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free